Latest filing published 02 Oct 2026 for Molina Healthcare, INC., €48k. Read the official filing
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Dale B. Wolf across 3 companies, led by Molina Healthcare, Inc., AdaptHealth Corp. and eHealth, Inc. Between 1 January 2016 and 1 October 2026, the trades on record add up to 57 filings.
On the open market, the record shows 11 purchases worth €1.9M and 6 sales worth €965k. On balance, insiders were net buyers of €964k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 35 share grants and 5 option exercises. So far in 2026, the count stands at 4 purchases and no sales.
Half of the purchases are above €109k and half below. Relative to company size, the median is 0.016% of market cap (3 purchases with a known value). 8 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 20% of cases; the median change was -8.0%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 2 October 2026 with a share grant (€48k) in Molina Healthcare, Inc. The most recent open-market purchase was published on 14 August 2026, 64 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 57 declarations